Abstract
R-levocetirizine, the racemic switch of (±)-cetirizine, is a potent H1-receptor antagonist. R-levocetirizine is currently marketed as oral dosage forms used to prevent and treat allergic conditions. In the present study, a stereoselective HPLC method was developed and optimized for the determination of cetirizine enantiomers in bulk and formulations by employing a chemometric tool. Chromatographic separation was carried out on a Chiralpak AS-3R analytical column (150 × 4.6 mm i.d., 3 µm). D-optimal mixture design was employed to study the effect of solvent composition, viz. acetonitrile (75–85%, v/v), MeOH (5–15%, v/v) and water (5–15%, v/v), by keeping other factors constant, such as mobile phase additives, flow rate (1.0 mL/min) and wavelength (235 nm) on output responses: retention factor and resolution of S- and R-enantiomers and analysis time. The mobile phase system comprising of acetonitrile−methanol−water−acetic acid−diethylamine (85 : 10 : 5 : 0.1 : 0.1, v/v) was selected as optimal by a graphical optimization trade-off technique. The proposed method was validated according to the ICH guidelines and successfully applied for the quantitation of cetirizine enantiomers in pharmaceutical dosage forms. The present study resulted in a fast and efficient liquid chromatographic method for the enantiopurity assessment of R-levocetirizine in real samples.
Similar content being viewed by others
REFERENCES
Nguyen, L.A., He, H., and Pham, H.C., Int. J. Biomed. Sci., 2006, vol. 2, p. 85.
Lees, P., Hunter, R.P., Reeves, P.T., and Toutain, P.L., J. Vet. Pharmacol. Ther., 2012, vol. 35, p. 17.
Somogyi, A., Bochner, F., and Foster, D., Aust. Prescriber, 2004, vol. 27, p. 109.
Valliappan, K. and Mannemala, S.S., J. Pharm. Biomed. Anal., 2016, vol. 120, p. 221.
Criado, P.R., Jardim Criado, R.F., Maruta, C.W., and d’Apparecida Machado Filho, C., An. Bras. Dermatol., 2010, vol. 85, p. 195.
Day, J.H., Ellis, A.K., and Rafeiro, E., Drugs Today, 2004, vol. 40, p. 415.
Gillard, M., Van, D.P.C., Moguilevsky, N., Massingham, R., and Chatelain, P., Mol. Pharmacol., 2002, vol. 61, p. 391.
Eom, H.Y., Kang, M., Kang, S.W., Kim, U., Suh, J.H., Kim, J., Cho, H.D., Jung, Y., Yang, D.H., and Han, S.B., J. Pharm. Biomed. Anal., 2016, vol. 117, p. 380.
Mikus, P., Maráková, K., Valásková, I., and Havránek, E., Pharmazie, 2009, vol. 64, p. 423.
Deng, X., Cock, D.B., Vervoort, R., Pamperin, D., Adams, E., and Schepdael, A.V., Chirality, 2012, vol. 24, p. 276.
Gupta, A., Jansson, B., Chatelain, P., Massingham, R., and Udenaes, M.H., Rapid Commun. Mass Spectrom., 2005, vol. 19, p. 1749.
Kang, S.W., Jang, H.J., Moore, V.S., Park, J.Y., Kim, K.A., Youm, J.R., and Han, S.B., J. Chromatogr. B: Anal. Technol. Biomed. Life Sci., 2010, vol. 878, p. 3351.
Taha, E.A., Salama, N.N., and Wang, S., Drug Test Anal., 2009, vol. 1, p. 118.
Gubitz, G. and Schmid, M.G., Biopharm. Drug Dispos., 2001, vol. 22, p. 291.
Hu, Y.P., Song, Y.R., Wang, D.F., Yang, Y.P., Hou, D.Y., and Ouyang, J., Chin. J. Pharm. Anal., 2004, vol. 24, p. 289.
Choi, S.O., Lee, S.H., Kong, H.S., Kim, E.J., and Choo, H.Y., J. Chromatogr. B: Biomed. Sci. Appl., 2000, vol. 744, p. 201.
Zhang, Z.F., Yang, G.L., Liang, G.J., Zhou, Y., and Chen, Y., Acta Pharm. Sin., 2004, vol. 39, p. 204.
Liu, Q., Zhang, Z., Bo, H., and Sheldon, R.A., Chromatographia, 2002, vol. 56, p. 233.
Mannemala, S.S. and Valliappan, K., J. AOAC Int., 2015, vol. 98, p. 1769.
Q2(R1) Validation of Analytical Procedures, Proc. Int. Conf. on Harmonization, Geneva: ICH, 2005.
Chankvetadze, B., Methods Mol. Biol., 2013, vol. 970, p. 81.
Scriba, G.K., J. Chromatogr. A, 2016, vol. 1467, p. 56.
Scriba, G.K., Methods Mol. Biol., 2013, vol. 970, p. 1.
Jibuti, G., Mskhiladze, A., Takaishvili, N., Karchkhadze, M., Chankvetadze, L., Farkas, T., and Chankvetadze, B., J. Sep. Sci., 2012, vol. 35, p. 2529.
Gogaladze, K., Chankvetadze, L., Tsintsadze, M., Farkas, T., and Chankvetadze, B., Chirality, 2015, vol. 27, p. 228.
Mosiashvili, L., Chankvetadze, L., Farkas, T., and Chankvetadze, B., J. Chromatogr. A, 2013, vol. 1317, p. 167.
Valliappan, K. and Mannemala, S.S., Chromatographia, 2014, vol. 77, p. 1203.
Valliappan, K. and Selvakumar, K., Chromatographia, 2017, vol. 80, p. 229.
Hibbert, D.B., J. Chromatogr. B: Anal. Technol. Biomed. Life Sci., 2012, vol. 910, p. 2.
Funding
The author is grateful to UGC-SAP DRS Phase-II sponsored Department of Pharmacy, Annamalai University, Tamil Nadu, India, UGC Major research project [MRP-MAJOR-BIOT-2013-39967] for providing the facilities to carry this research work and also for the financial assistance through UGC-BSR fellowship.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Valliappan Kannappan, Selvakumar Kanthiah Development and Optimization of Stereoselective Liquid Chromatographic Method for Chiral Separation of (±)-cetirizine and Enantiopurity Assessment of R-levocetirizine. J Anal Chem 75, 349–357 (2020). https://doi.org/10.1134/S1061934820030090
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1061934820030090